Brain, E <br/><br/>
Long-term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy.  [electronic resource] 

 -  British journal of cancer  1997 
 - 1360-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0007-0920 
<br/><br/><label>Standard No.: </label>10.1038/bjc.1997.230  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Breast Neoplasms--pathology<br/>Chemotherapy, Adjuvant<br/>Cyclophosphamide--therapeutic use<br/>Disease Progression<br/>Disease-Free Survival<br/>Doxorubicin--therapeutic use<br/>Female<br/>Fluorouracil--therapeutic use<br/>Humans<br/>Lymph Nodes--pathology<br/>Middle Aged<br/>Neoplasm Staging<br/>Postmenopause<br/>Premenopause<br/>Prognosis<br/>Retrospective Studies<br/>Survival Analysis<br/>Vincristine--therapeutic use